OUR RESEARCH IS ABOUT MORE THAN YOUR DISEASE. OUR RESEARCH IS ABOUT YOU.
WE ADVANCE SCIENTIFIC RESEARCH AND DISCOVERY in rheumatology through meaningful human connections, providing a deeper understanding of rheumatic and musculoskeletal diseases and empowering improved treatments, disease management, and lifestyles.
WE ARE RELENTLESS in searching for scientifically-based answers; armed with our empathy, our compassion, and our curiosity we seek to grow our collective knowledge by learning from the past to understand the future—drawing insights from the stories you share.
WE HAVE A PIONEERING HISTORY of reaching beyond the boundaries of what’s comfortable and making real impacts on the lives of the patients we serve.
WE CHAMPION YOUR VOICE as the expert in how rheumatic disease impacts your life. Through our research, and with your help, we continue to improve diagnosis, treatment, and outcomes—all driven by our ultimate goal: the prevention and cure of rheumatic and musculoskeletal diseases.
WE FUEL THE NEXT GENERATION of researchers and specialists so that one day, we can all enjoy a life free of affliction from rheumatic diseases.
WE ARE FORWARD—JOIN US, AND TOGETHER, WE MOVE FORWARD.
FORWARD partners with patient participants, who make a difference in rheumatic disease research by donating their time to completing a twice-yearly questionnaire about their rheumatic disease symptoms, treatment, and experience.
Health Care Providers
FORWARD partners with health care providers from medical practices and academic centers to ensure that the patient voice is heard within research, a vital aspect necessary to improve the diagnosis, treatment, and prevention of rheumatic diseases.
FORWARD partners with academic and pharmaceutical researchers to improve our understanding of rheumatic diseases through data analysis, safety study management, and other research support and assistance.
Information about recent research performed by FORWARD collaborators using FORWARD data.
RA Treatments Work, but Raise Infection Risk
The authors of this study, which was led by Kaleb Michaud, Ph.D., of the University of Nebraska Medical Center in Omaha, concluded that despite the efficacy of biologic DMARDs…
Relative Impact of Pain and Fatigue on Work Productivity in Patients with Rheumatoid Arthritis
To explore the relationship of pain and fatigue with daily activity and work productivity in rheumatoid arthritis (RA) patients from the baricitinib clinical trial, RA-BEAM.
Safety of abatacept compared with other biologic and conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
To assess the risks of malignancies, infections and autoimmune diseases in patients with rheumatoid arthritis (RA) treated with abatacept…
“We take a long look at the outcomes of these illnesses. This allows us to conduct observational studies that tell us, for example, how well a drug works under real-life circumstances, unlike clinical trials, which tell you only how well a drug can work under idealized circumstances.”